# Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers

> **NCT06304129** · NA · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 189 (estimated)

## Conditions studied

- Alzheimer Blood Biomarkers

## Interventions

- **DIAGNOSTIC_TEST:** Blood ponction

## Key facts

- **NCT ID:** NCT06304129
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2026-01-02
- **Final completion:** 2026-09-02
- **Target enrollment:** 189 (ESTIMATED)
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304129, "Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06304129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*